6hvd
From Proteopedia
(Difference between revisions)
(New page: ==Human SLK bound to a maleimide inhibitor== <StructureSection load='6hvd' size='340' side='right' caption='6hvd, resolution 1.63Å' scene=''> == Structural highli...) |
|||
(One intermediate revision not shown.) | |||
Line 1: | Line 1: | ||
==Human SLK bound to a maleimide inhibitor== | ==Human SLK bound to a maleimide inhibitor== | ||
- | <StructureSection load='6hvd' size='340' side='right' caption='[[6hvd]], [[Resolution|resolution]] 1.63Å' scene=''> | + | <StructureSection load='6hvd' size='340' side='right'caption='[[6hvd]], [[Resolution|resolution]] 1.63Å' scene=''> |
== Structural highlights == | == Structural highlights == | ||
- | <table><tr><td colspan='2'>[[6hvd]] is a 1 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6HVD OCA]. For a <b>guided tour on the structure components</b> use [ | + | <table><tr><td colspan='2'>[[6hvd]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6HVD OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=6HVD FirstGlance]. <br> |
- | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=EDO:1,2-ETHANEDIOL'>EDO</scene>, <scene name='pdbligand=GUQ:3-(1,3-benzothiazol-2-ylamino)-4-(2-methoxyphenyl)pyrrole-2,5-dione'>GUQ</scene>, <scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene | + | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 1.63Å</td></tr> |
- | + | <tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=EDO:1,2-ETHANEDIOL'>EDO</scene>, <scene name='pdbligand=GUQ:3-(1,3-benzothiazol-2-ylamino)-4-(2-methoxyphenyl)pyrrole-2,5-dione'>GUQ</scene>, <scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene></td></tr> | |
- | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[ | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=6hvd FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6hvd OCA], [https://pdbe.org/6hvd PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=6hvd RCSB], [https://www.ebi.ac.uk/pdbsum/6hvd PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=6hvd ProSAT]</span></td></tr> |
</table> | </table> | ||
== Function == | == Function == | ||
- | [ | + | [https://www.uniprot.org/uniprot/SLK_HUMAN SLK_HUMAN] Mediates apoptosis and actin stress fiber dissolution. |
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> | ||
- | [[Category: | + | [[Category: Homo sapiens]] |
- | [[Category: Arrowsmith | + | [[Category: Large Structures]] |
- | [[Category: Bailey | + | [[Category: Arrowsmith C]] |
- | [[Category: Berger | + | [[Category: Bailey HJ]] |
- | [[Category: Bountra | + | [[Category: Berger BT]] |
- | [[Category: Burgess-Brown | + | [[Category: Bountra C]] |
- | + | [[Category: Burgess-Brown NA]] | |
- | [[Category: Edwards | + | [[Category: Edwards AM]] |
- | [[Category: Elkins | + | [[Category: Elkins JM]] |
- | [[Category: Knapp | + | [[Category: Knapp S]] |
- | [[Category: Krojer | + | [[Category: Krojer T]] |
- | [[Category: Pinkas | + | [[Category: Pinkas D]] |
- | [[Category: Salah | + | [[Category: Salah E]] |
- | [[Category: Savitsky | + | [[Category: Savitsky PA]] |
- | [[Category: Serafim | + | [[Category: Serafim RAM]] |
- | [[Category: Sorrell | + | [[Category: Sorrell FJ]] |
- | [[Category: | + | [[Category: Von Delft F]] |
- | + |
Current revision
Human SLK bound to a maleimide inhibitor
|
Categories: Homo sapiens | Large Structures | Arrowsmith C | Bailey HJ | Berger BT | Bountra C | Burgess-Brown NA | Edwards AM | Elkins JM | Knapp S | Krojer T | Pinkas D | Salah E | Savitsky PA | Serafim RAM | Sorrell FJ | Von Delft F